Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term biological effects of zoledronate and letrozole on invasive breast cancer
2004-004223-36Phase 4Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Jul 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of letrozole and zoledronic acid in breast cancer, sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Ki67 reduction. Started Jul 2005; status: completed.
02
Drugs
letrozolezoledronic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2004-004223-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004223-36.